KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like GlaxoSmithKline Gets Expanded FDA Win for Fluarix January 11, 2018 Effective Immediately: Advaxis CEO Resigns, Interim Leader Named July 6, 2017 Bay Area's Global Blood Therapeutics Terminates Lung Disease Program October 22, 2017
